Moreover, low levels of ATAD2 expression were reported after a comparison of metastatic and nonmetastatic breast cancer patients and controls, which differed from plausibly consistent viewpoints that ATAD2 was highly expressed in many cancers [22]. Here, ATAD2 is linked to breast carcinoma.